TY  - RPRT
TI  - SAMHD1 controls nucleoside-based cancer therapeutics, deoxyguanosine toxicity, and inflammation
AU  - Moore, M. D.
AU  - Johnson, E.
AU  - Jacklin, C.
AU  - Johnson, S.
AU  - Green, O.
AU  - James, W. S.
PY  - 2022
DO  - 10.1101/2022.08.25.505278
UR  - https://www.biorxiv.org/content/10.1101/2022.08.25.505278v1
ID  - 10.1101/2022.08.25.505278
ER  -